No Data
Pacific Biosciences of California (NASDAQ:PACB) Shares Up 3.9%
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) shot up 3.9% during trading on Wednesday . The company traded as high as $6.08 and last traded at $6.06. 42,602 shares wer
The President of Pacific Biosciences of California, Inc. (NASDAQ:PACB), Christian O. Henry, Just Sold 32% Of Their Holding
Some Pacific Biosciences of California, Inc. (NASDAQ:PACB) shareholders may be a little concerned to see that the President, Christian O. Henry, recently sold a substantial US$527k worth of stock at a
Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3% Following Insider Selling
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) shares fell 5.3% during mid-day trading on Tuesday following insider selling activity. The stock traded as low as $5.73 and last tra
Trellus Management Company LLC Buys 40,000 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Trellus Management Company LLC raised its stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) by 100.0% during the 2nd quarter, according to the company in its most
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $527,754.46 in Stock
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) insider Christian O. Henry sold 91,307 shares of the stock in a transaction dated Thursday, September 15th. The stock was sold at an
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 8.6%
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating)'s stock price dropped 8.6% during mid-day trading on Tuesday . The company traded as low as $6.23 and last traded at $6.35. Approxim
Pacific Biosciences Of California To Present At Morgan Stanley Conference; Webcast At 1:30 PM ET
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers Akero Therapeutics, Inc. (NASDAQ:AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX d
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.Akero Therapeutics, Inc. (NASDAQ:AKRO) shares climbed 111% to
Granahan Investment Management LLC Lowers Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Granahan Investment Management LLC lessened its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) by 15.7% in the 1st quarter, according to the company in its most recent 1
Loading...
